Masahiro Kitada

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial

Masakazu Toi, Shigeru Imoto, Takanori Ishida et al. · The Lancet Oncology · 2020 · 62 citations

Medicine, Endocrinology, Oncology +16

Aluminum potassium sulfate and tannic acid (ALTA) injection as the mainstay of treatment for internal hemorrhoids

Yoshikazu Hachiro, Masao Kunimoto, Tatsuya Abe et al. · Surgery Today · 2011 · 59 citations

Medicine, Surgery, Hemostasis +5

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato et al. · The Journal of Experimental Medicine · 2021 · 55 citations · Full text

Medicine, Immunology, Oncology +17

IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases

Masahiro Kitada, Yoshinari Matuda, Satoshi Hayashi et al. · Journal of Cardiothoracic Surgery · 2013 · 43 citations · Full text

Medicine, Oncology, Radiology +16

Esophageal schwannoma: a case report

Masahiro Kitada, Yoshinari Matsuda, Satoshi Hayashi et al. · World Journal of Surgical Oncology · 2013 · 41 citations · Full text

Medicine, Oncology, Surgery +10